These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 15168732)
1. Identification of metastasis-associated proteins through protein analysis of metastatic MDA-MB-435 and metastasis-suppressed BRMS1 transfected-MDA-MB-435 cells. Cicek M; Samant RS; Kinter M; Welch DR; Casey G Clin Exp Metastasis; 2004; 21(2):149-57. PubMed ID: 15168732 [TBL] [Abstract][Full Text] [Related]
2. Breast cancer metastasis suppressor 1 inhibits gene expression by targeting nuclear factor-kappaB activity. Cicek M; Fukuyama R; Welch DR; Sizemore N; Casey G Cancer Res; 2005 May; 65(9):3586-95. PubMed ID: 15867352 [TBL] [Abstract][Full Text] [Related]
4. Downregulation of osteopontin contributes to metastasis suppression by breast cancer metastasis suppressor 1. Hedley BD; Welch DR; Allan AL; Al-Katib W; Dales DW; Postenka CO; Casey G; Macdonald IC; Chambers AF Int J Cancer; 2008 Aug; 123(3):526-34. PubMed ID: 18470911 [TBL] [Abstract][Full Text] [Related]
5. Functional evidence for a novel human breast carcinoma metastasis suppressor, BRMS1, encoded at chromosome 11q13. Seraj MJ; Samant RS; Verderame MF; Welch DR Cancer Res; 2000 Jun; 60(11):2764-9. PubMed ID: 10850410 [TBL] [Abstract][Full Text] [Related]
6. Alterations of BRMS1-ARID4A interaction modify gene expression but still suppress metastasis in human breast cancer cells. Hurst DR; Xie Y; Vaidya KS; Mehta A; Moore BP; Accavitti-Loper MA; Samant RS; Saxena R; Silveira AC; Welch DR J Biol Chem; 2008 Mar; 283(12):7438-44. PubMed ID: 18211900 [TBL] [Abstract][Full Text] [Related]
7. Identification of the functional role of peroxiredoxin 6 in the progression of breast cancer. Chang XZ; Li DQ; Hou YF; Wu J; Lu JS; Di GH; Jin W; Ou ZL; Shen ZZ; Shao ZM Breast Cancer Res; 2007; 9(6):R76. PubMed ID: 17980029 [TBL] [Abstract][Full Text] [Related]
8. Metastasis suppression by breast cancer metastasis suppressor 1 involves reduction of phosphoinositide signaling in MDA-MB-435 breast carcinoma cells. DeWald DB; Torabinejad J; Samant RS; Johnston D; Erin N; Shope JC; Xie Y; Welch DR Cancer Res; 2005 Feb; 65(3):713-7. PubMed ID: 15705865 [TBL] [Abstract][Full Text] [Related]
9. Differentially expressed genes associated with the metastatic phenotype in breast cancer. Kirschmann DA; Seftor EA; Nieva DR; Mariano EA; Hendrix MJ Breast Cancer Res Treat; 1999 May; 55(2):127-36. PubMed ID: 10481940 [TBL] [Abstract][Full Text] [Related]
10. The C-terminal putative nuclear localization sequence of breast cancer metastasis suppressor 1, BRMS1, is necessary for metastasis suppression. Hurst DR; Xie Y; Thomas JW; Liu J; Edmonds MD; Stewart MD; Welch DR PLoS One; 2013; 8(2):e55966. PubMed ID: 23390556 [TBL] [Abstract][Full Text] [Related]
11. Breast cancer metastasis suppressor 1 up-regulates miR-146, which suppresses breast cancer metastasis. Hurst DR; Edmonds MD; Scott GK; Benz CC; Vaidya KS; Welch DR Cancer Res; 2009 Feb; 69(4):1279-83. PubMed ID: 19190326 [TBL] [Abstract][Full Text] [Related]
12. Suppression of human ovarian carcinoma metastasis by the metastasis-suppressor gene, BRMS1. Zhang S; Lin QD; DI W Int J Gynecol Cancer; 2006; 16(2):522-31. PubMed ID: 16681721 [TBL] [Abstract][Full Text] [Related]
13. Identification and characterization of the murine ortholog (brms1) of breast-cancer metastasis suppressor 1 (BRMS1). Samant RS; Debies MT; Shevde LA; Verderame MF; Welch DR Int J Cancer; 2002 Jan; 97(1):15-20. PubMed ID: 11774238 [TBL] [Abstract][Full Text] [Related]
15. Identification and validation of metastasis-associated proteins in head and neck cancer cell lines by two-dimensional electrophoresis and mass spectrometry. Wu W; Tang X; Hu W; Lotan R; Hong WK; Mao L Clin Exp Metastasis; 2002; 19(4):319-26. PubMed ID: 12090472 [TBL] [Abstract][Full Text] [Related]
16. Proteomics-based strategy to delineate the molecular mechanisms of the metastasis suppressor gene BRMS1. Rivera J; Megias D; Bravo J J Proteome Res; 2007 Oct; 6(10):4006-18. PubMed ID: 17854218 [TBL] [Abstract][Full Text] [Related]
17. Multiple forms of BRMS1 are differentially expressed in the MCF10 isogenic breast cancer progression model. Hurst DR; Xie Y; Edmonds MD; Welch DR Clin Exp Metastasis; 2009; 26(2):89-96. PubMed ID: 18841483 [TBL] [Abstract][Full Text] [Related]
18. Differential proteomic analysis of a highly metastatic variant of human breast cancer cells using two-dimensional differential gel electrophoresis. Xu SG; Yan PJ; Shao ZM J Cancer Res Clin Oncol; 2010 Oct; 136(10):1545-56. PubMed ID: 20155427 [TBL] [Abstract][Full Text] [Related]
19. Proteomic profiling identifies breast tumor metastasis-associated factors in an isogenic model. Kreunin P; Yoo C; Urquidi V; Lubman DM; Goodison S Proteomics; 2007 Jan; 7(2):299-312. PubMed ID: 17205601 [TBL] [Abstract][Full Text] [Related]
20. Gene expression profile analysis of an isogenic tumour metastasis model reveals a functional role for oncogene AF1Q in breast cancer metastasis. Li DQ; Hou YF; Wu J; Chen Y; Lu JS; Di GH; Ou ZL; Shen ZZ; Ding J; Shao ZM Eur J Cancer; 2006 Dec; 42(18):3274-86. PubMed ID: 16979889 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]